Novel agents for advanced bladder cancer. - Wikidata - wikimedia - TriplyDB

Novel agents for advanced bladder cancer.

Novel agents for advanced bladder cancer.

http://www.wikidata.org/entity/Q35076184

about

Novel agents for advanced bladder cancer.

http://www.wikidata.org/entity/Q35076184

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Novel agents for advanced bladder cancer.

@ast

Novel agents for advanced bladder cancer.

@en

type

label

Novel agents for advanced bladder cancer.

@ast

Novel agents for advanced bladder cancer.

@en

prefLabel

Novel agents for advanced bladder cancer.

@ast

Novel agents for advanced bladder cancer.

@en

P1433

Q35076184-F926DD97-4F58-40E5-8F03-C749DBAA110B

P1476

Q35076184-0269DF0C-6601-4E43-9D71-FA516E21FCC6

P2093

Q35076184-2600E323-DA87-40D1-93AD-AB713C4F8048

Q35076184-55F66010-C03E-467E-B350-B8984BDCE78D

Q35076184-F7A9822A-CE7E-4968-BE73-74EC9C7AF79A

P2860

Q35076184-00ADCA96-424C-4856-9AFD-6DD69C01C5B3

Q35076184-0E3EFE97-8F41-436D-A15B-24CF9F656296

Q35076184-0EBB6031-406B-4F14-93E9-F6C7E13C2988

Q35076184-12E3BA5F-5A46-46E9-A872-833ED8828BE1

Q35076184-1563DABC-C657-4A56-9DC8-26FBBCB7E60E

Q35076184-17C2B780-399F-47B7-94F3-C93C5F05DE87

Q35076184-17FCBECE-C046-4BB1-98D7-F094BE75844A

Q35076184-18F2E812-47FB-4D0C-90F1-8E305EA5EC48

Q35076184-1BC3A6DD-380F-43AE-A92F-E2C4509EA61C

Q35076184-29A3E1FD-3621-49B0-B43B-AA6025C615AA

P304

Q35076184-311B3EF3-3888-4104-BBA2-2BC3180BD51F

P31

Q35076184-BA071ADF-AB1F-4CFF-A76A-CBDD43ABD5F1

P356

Q35076184-2B0F954E-F832-4EB5-B154-9A241F50821A

P433

Q35076184-C2E4C6DF-65C0-4F1A-8E17-511B1ADACBD7

P478

Q35076184-111A48DB-8E18-465E-8E57-7356590FDEE8

P577

Q35076184-F67BF7C1-29C7-4ECE-8A1F-971A7B24E886

P5875

Q35076184-C1DB2959-1173-4733-82BC-5E966C74AF72

P698

Q35076184-4B9AC0B9-9AE1-4808-AF68-32DC957DD3AC

P932

Q35076184-374508D3-0BE3-4783-AD19-9ED0A314DCEA

P356

1758834009337776

P1433

Therapeutic advances in medical oncology

P1476

Novel agents for advanced bladder cancer.

@en

P2093

Aymen A Elfiky

http://www.w3.org/2001/XMLSchema#string

Guru Sonpavde

http://www.w3.org/2001/XMLSchema#string

Jonathan E Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: a phase II multicenter trial.

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.

Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.

A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium.

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207.

P304

37-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834009337776

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51521152

http://www.w3.org/2001/XMLSchema#string

P698

21789112

http://www.w3.org/2001/XMLSchema#string

P932

3125992

http://www.w3.org/2001/XMLSchema#string